Chemo Experts, the easiest way to learn about cancer treatment
Find a Treatment:
Cancer Types

Treatment Name: Capecitabine (Xeloda®)

Capecitabine (Xeloda®) is a Chemotherapy Regimen for Breast Cancer - metastatic

How does capecitabine work?
Capecitabine is designed to slow the growth of and kill breast cancer cells by preventing DNA synthesis inside cancer cells. Capecitabine may also prevent cancer cells from making certain proteins needed for their survival by interfering with RNA.

Goals of therapy:
Capecitabine is taken to shrink tumors and decrease symptoms of breast cancer. If breast cancer is early stage (cancer is limited to breast tissue or surrounding lymph nodes), capecitabine is commonly given with the goal of cure. If breast cancer is advanced or metastatic (cancer has spread to other areas of the body), capecitabine is not commonly given with the goal of cure, but rather to shrink breast tumors, and decrease symptoms from breast cancer.


Create your own Treatment Tracker

  • Usual starting dose: 3 - 5 tablets (depending upon your height, weight, and kidney function) by mouth twice daily for 14 days every 21 days

Capecitabine is usually taken at home. Several tablets will need to be taken with each dose to equal the total dose prescribed. The number of tablets will vary depending on the dose and strength of the tablets prescribed.

Click here for common starting doses

Capecitabine is taken every day, TWICE Daily, for 14 days then is NOT taken for 7 days. This is known as one Cycle. Each cycle is 21 days (3 weeks) and may be repeated until it no longer works or until unacceptable side effects are seen.

Side Effects

In clinical studies, the most commonly reported side effects with capecitabine are shown here. Side effects sometimes have percentage ranges [example 37 – 47%] because they differed between in clinical studies:

  • Skin reaction on the palms of hands and soles of feet (37 - 47%)
  • Nausea (33 - 44%)
  • Fatigue (20 - 47%)
  • Diarrhea (18 - 30%)
  • Mouth sores (17%)
  • Vomiting (13 - 16%)
  • Shortness of breath (7 - 20%)
  • Pain (9 - 17%)
  • Low white blood cells (7 - 11%)
  • Increased bleeding risk [low platelets] (3 - 5%)
  • Anemia [low red blood cells] (3%)

Side effect videos Side Effect Videos
Nausea and VomitingNausea and VomitingFatigue Fatigue DiarrheaDiarrheaPainPainAnemiaAnemia


How often is monitoring needed?
Labs (blood tests) may be checked before treatment (every 21 days), or periodically during treatment until stable. Labs often include: Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), plus any others your doctor may order.

How often is imaging needed?
Imaging may be checked before treatment, periodically during treatment, and at the end of treatment. Imaging may include: computerized tomography (CT) scans or positron emission tomography (PET) scans.

How might blood test results/imaging affect treatment?
Depending upon the results, your doctor may advise to continue capecitabine as planned, or delay or switch therapy

ChemoExperts Tips

  • May cause painful redness, blistering, and peeling skin reaction on the palms of your hands and on the soles of your feet. This is known as Hand-Foot Syndrome. Ways to help reduce the risk of experiencing Hand-Foot Syndrome include using a non-alcoholic moisturizer daily on your hands and feet, avoid wearing gloves, avoid prolonged exposure to hot water, and avoid activities that put pressure or friction on your hands and feet such as golf or tennis while taking capecitabine
  • Nausea and mouth sores may be more common in patients with kidney problems. Dose reductions may be necessary if your kidneys are not working well
  • If an accidental overdose occurs, contact your doctor and go to the emergency room immediately. In severe cases, an antidote called uridine triacetate (Vistogard®) may be given to protect healthy cells and decrease side effects
  • A pharmacist should ALWAYS review your medication list to ensure that drug interactions are prevented or managed appropriately
  • Clinical trials may exist for breast cancer. Ask your doctor if any studies are currently enrolling in your area. If not, go to to search for other centers offering study medications

Patient Assistance & Co-payment Coverage

Patients under the age of 65 years, or those with private insurance plans:
If you have insurance and are looking for patient assistance or copay assistance for Capecitabine (Xeloda®), we have provided links that may help.

Visit our Patient Assistance page and click the links to various patient assistance programs for help paying for Capecitabine (Xeloda®). Depending upon your income, they may be able to help cover the cost of:

  • Capecit­abine

For Branded medications (may be available for generic medications too), check with the manufacturer to determine if a co-pay card is offered and if it could reduce your monthly copay.

  • If you are uninsured, check with the manufacturer to determine if you are eligible to receive medication at no cost.

Medicare and Medicaid patients (Patients 65 years or older):
The clinic providing treatment will likely pre-authorize medications and immune therapies such as Capecitabine (Xeloda®) and are the best source to help you understand drug cost.

  • Ask to speak with a patient assistance technician or financial counselor at the clinic or hospital administering this therapy.

Emotional Wellness

What is Emotional Wellness?
Emotional wellness is having a positive outlook balanced with a realistic understanding of current life events. This requires both an awareness and acceptance of your emotions. It is with this knowledge that you can develop a plan to take the necessary actions to positively impact your life.

Emotional wellness uses an ongoing process to continually reflect on the stressors of life in a constructive manner to move forward and create happiness.

Because emotional wellness is deeply connected with physical, social, and spiritual wellness, pursuing it often becomes particularly difficult in times of major illness. Despite this difficulty, working toward emotional wellness has been connected to improved treatment outcomes and a higher likelihood of achieving goals of therapy.

Learn more about pursuing emotional wellness while receiving treatment with Capecitabine (Xeloda®)

Individual Drug Label Information

Capecit­abine (Xeloda®)

  • Capecitabine Is an oral tablet with two strengths: 150 mg and 500 mg tablets
  • Swallow tablets whole with water.  Take within 30 minutes after eating a meal
  • A dose may combine both tablet strengths and multiple tablets of each (see manufacturer’s package insert for dose/tablet calculation table)
  • Doses are usually divided; taken twice daily, 12 hours apart
  • There is a strong drug interaction with certain blood thinner medications (anticoagulants) like warfarin (Coumadin) that can increase bleeding.  Doses of both capecitabine and the anticoagulants may have to be adjusted.  Immediately report any bleeding  while on capecitabine
  • There are drug interactions with phenytoin (Dilantin) and leucovorin.  Ask your doctor or pharmacist to review your medications before starting capecitabine
  • May cause fetal harm, avoid this drug during pregnancy
General Capecitabine (Xeloda) Side Effects
  • Diarrhea
  • Nausea and vomiting
  • Abdominal pain
  • Heart problems
  • Fatigue
  • Dehydration and kidney failure
  • Mouth sores (stomatitis)
  • Constipation
  • Hand-foot syndrome. Treat with a non-alcoholic moisturizer
  • Dry skin
  • Eye irritation
  • Nerve pain, tingling sensation in fingers and toes
  • Lack of appetite (anorexia)
  • Bleeding
  • Liver toxicity. Baseline and regular blood tests are necessary
  • Age greater than 60 years is associated with a higher incidence of all side effects
  • Click on the capecitabine (Xeloda) package insert below for reported side effects and possible drug interactions

Side Effect Videos
Nausea and VomitingNausea and VomitingDiarrheaDiarrheaFatigue Fatigue BleedingBleedingConstipationConstipationPainPainAnemiaAnemiaNeutropenic FeverNeutropenic FeverBlood ClotsBlood Clots

See DailyMed package insert.

Share this page:


Bajetta E, Procopio G, Celio L, et al. Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women. J Clin Oncol. 2005;23:2155-2161.

Created: March 6, 2016 Updated: September 27, 2018

What is Breast Cancer - metastatic?

What is Metastatic Breast Cancer?
A disease of the milk-producing glands known as lobules, milk ducts, or other cells found in the breast. Metastatic breast cancer is one that has moved from the breast to other areas of the body, which may include the brain, liver, or bone. Breast cancer is one of the most common types of cancers in women, but may rarely affect men as well. Known causes of breast cancer include genetic causes, such as the BRCA mutation, or obesity. The effectiveness of the treatment may depend upon the stage at diagnosis.

Types of metastatic breast cancer:
1. Hormone-receptor positive or negative (60 - 65% of patients)

  • Estrogen Receptor positive (ER)+ or negative (ER)-
  • Progestin Receptor positive (PR)+ or negative (PR)-

2. Hormone Epidermal growth factor Receptor-2 (HER-2) positive or negative (20 - 25% of patients)

  • HER-2 +
  • HER-2 -

3. Triple Negative (15 - 18% of patients)

  • ER- and PR- and (HER-2)-
NOTE: Treatment Options listed below are not all-inclusive. Other treatments may be available. ChemoExperts provides drug information and does not recommend any one treatment over another. Only your Doctor can choose which therapy is appropriate for you.

Common Starting Dose

Usual starting dose: Capecitabine 1000 - 1250 mg/m2 by mouth TWICE Daily for 14 days, then no drug for 7 days. This cycle is repeated every 21 days

What is a CBC?

A Complete Blood Count (CBC) is a frequently ordered blood test that tells clinicians the status of your: 1) White blood cell count, 2) Hemoglobin, and 3) Platelet count at the time the test was taken.

Common uses:
1) White blood cell count (WBC): is used to determine infection risk, or response to chemotherapy. Certain chemotherapy agents may harm our good infection-fighting cells. Sometimes chemotherapy may need to be delayed to allow these cells to recover.

2) Hemoglobin: is used to determine if someone is anemic. Anytime the hemoglobin is below 12 g/dL, the person is said to be anemic. Red blood cell transfusions, and sometimes iron can be given to restore the hemoglobin level, but anemia treatment should always aim at treating the underlying cause or condition.

3) Platelet count: is used to determine if the risk of bleeding is increased or if a platelet transfusion is required to prevent bleeding. Certain medications that increase bleeding risk, such as: aspirin, certain chemotherapy agents, and blood thinners, may need to be stopped temporarily until the platelet count is within a safe range.

What is a CMP?

A Comprehensive Metabolic Panel (CMP) is a frequently ordered blood test that tells clinicians the status of your: 1) Electrolytes & Acid/Base status2) Kidney function, 3) Liver function, 4) Blood sugar, and 5) Calcium at the time the test was taken. It is commonly used to monitor liver and kidney function when beginning new medications such as chemotherapy. A total of 14 tests are run simultaneously and are shown below.

Electrolytes & Acid/Base status:
1) Sodium, 2) Potassium, 3) Carbon dioxide, 4) Chloride

Kidney Function:
5) BUN (blood urea nitrogen), 6) Serum creatinine (Scr)

Liver Function:
7) AST, 8) ALT, 9) Total bilirubin, 10) Alk Phos, 11) Albumin, 12) Total protein

Blood sugar:
13) Serum glucose

14) Serum calcium

What does Cure mean?

The word “cure” means there are no cancer cells left in the body and cancer will never come back. Depending on the cancer type and stage, this may be the true goal of therapy. However, it is very difficult to prove all cancer cells are gone. Even though images, like X-rays and MRI’s, and blood tests may not show any signs of cancer, there can be a small amount of cancer cells still left in the body. Because of this, the word “remission” is used more often. This means there are no signs or symptoms of cancer. Patients in remission are followed closely for any signs of cancer returning. Sometimes, more chemotherapy may be given while in remission to prevent the cancer from coming back.

Doctors usually do not consider a patient “cured” until the chance of cancer returning is extremely low. If cancer does return, it usually happens within 5 years of having a remission. Because of this, doctors do not consider a patient cured unless the cancer has not come back within 5 years of remission. The five-year cutoff does not apply to all cancers.